Tuberculosis meningitis treatment adjunct

Tuberculosis meningitis treatment adjunct refers to supplementary therapy administered alongside standard antitubercular regimens to manage tuberculous meningitis, a severe and often fatal central nervous system infection caused by *Mycobacterium tuberculosis* dissemination Affecting children and adults—particularly immunocompromised individuals such as those living with HIV—the disease is characterized by subacute leptomeningeal inflammation, dense basal exudates, cerebral vasculitis, and eleva...

Tuberculosis meningitis treatment adjunct refers to supplementary therapy administered alongside standard antitubercular regimens to manage tuberculous meningitis, a severe and often fatal central nervous system infection caused by *Mycobacterium tuberculosis* dissemination Affecting children and adults—particularly immunocompromised individuals such as those living with HIV—the disease is characterized by subacute leptomeningeal inflammation, dense basal exudates, cerebral vasculitis, and eleva...

Affecting children and adults—particularly immunocompromised individuals such as those living with HIV—the disease is characterized by subacute leptomeningeal inflammation, dense basal exudates, cerebral vasculitis, and elevated intracranial pressure Adjunctive agents, notably anti-inflammatory corticosteroids, target the hyperactive host immune response responsible for critical complications such as cerebral infarction, hydrocephalus, and persistent neurological deficits, aiming to reduce overa...

Adjunctive agents, notably anti-inflammatory corticosteroids, target the hyperactive host immune response responsible for critical complications such as cerebral infarction, hydrocephalus, and persistent neurological deficits, aiming to reduce overall mortality and morbidity